Assignee
ASCLETIS PHARMA CHINA CO LTD
CN·2 granted patents·5 pending applications·4 citations·filing 2024–2025
Top patents by PatentIndex Score
7 records- 0194US12234236B1GLP-1R agonist and therapeutic method thereofASCLETIS PHARMA CHINA CO LTD·Filed 2024·Granted Feb 25, 2025·3 cites·25 claims
- 0289US12291530B1GLP-1R agonist and therapeutic method thereofASCLETIS PHARMA CHINA CO LTD·Filed 2024·Granted May 6, 2025·1 cites·13 claims
- 0383US2025346594A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0483US2025346596A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0583US2025346595A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0673US2025376470A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0759US2025257062A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASCLETIS PHARMA CHINA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →